Telemerase - A potential molecular marker of lung and cervical cancer

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 10, 2002, Pages 994-1001

  Sen, Sudip ^a   Reddy, Vijay G ^a   Guleria, Randeep ^a   Jain, Sunesh K ^a   Kapila, Kusum ^a   Singh, Neeta ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cervical cancer; Diagnosis; Lung cancer; Telomerase

Indexed keywords

MOLECULAR MARKER; TELOMERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CANCER SCREENING; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOPATHOLOGY; DISEASE MARKER; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LUNG BIOPSY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; SPUTUM ANALYSIS; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TRACHEOBRONCHIAL TOILET; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS; CANCER STAGING; COMPARATIVE STUDY; DNA PROBE; ENZYMOLOGY; ISOLATION AND PURIFICATION; LUNG TUMOR; METABOLISM; MIDDLE AGED; PAPILLOMA VIRUS; SPUTUM; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; VIROLOGY;

HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DNA PROBES, HPV; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; SPUTUM; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0036429339     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.173     Document Type: Article

References (35)

1. Alani RM, Munger K. Human papillomavirus and associated malignancies. J Clin Oncol 1998; 16:330-7.
2. Howley PM. Role of the human papillomaviruses in human cancer. Cancer Res 1991; 51:5019-22.
3. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992; 79:328-37.
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9.
5. Shiga T, Shirasawa H, Shimizu K, Dezawa M, Masuda Y, Simizu B. Normal human fibroblasts immortalized by introduction of human papillomavirus type 16 (HPV-16) E6-E7 genes. Microbiol Immunol 1997; 41:313-9.
6. Pass HI, Mitchell JB, Johnson DH, Turrisi AT, editors. Lung cancer: principles and practice. Philadelphia: Lippincott-Raven, 1996.
7. Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol 1996; 8:66-71.
8. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1982.
9. Das BC, Sharma JK, Gopalkrishna V, Das DK, Singh V, Gissmann L, et al. A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol 1992; 36:239-45.
10. Fujiwara H, Mitchell MF, Arseneau J, Hale RJ, Wright TC. Clear cell adenosquamous carcinoma of the cervix. An aggressive tumor associated with human papillomavirus-18. Cancer 1995; 76:1591-600.
11. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-5.
12. Sharma ND, Balasubramanian S, Khanna N, Bahadur S, Chattopadhyay TK, Singh N. Telomerase activity in Indian patients with carcinomas of the aerodigestive tract. Tumor Biol 1999; 20:225-32.
13. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 77:248-54.
14. Das BC, Gopalkrishna V, Das DK, Sharma JK, Singh V, Luthra UK. Human papillomavirus DNA sequences in adenocarcinoma of the uterine cervix in Indian women. Cancer 1993; 72:147-53.
15. Chatterjee R, Roy A, Basu S. Detection of type specific human papillomavirus (HPV) DNA in cervical cancers of Indian women. Indian J Pathol Microbiol 1995; 38:33-42.
16. Zhang DK, Ngan HY, Cheng RY, Cheung AN, Liu SS, Tsao SW. Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer. Eur J Cancer 1999; 35:154-60.
17. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996; 88:116-22.
18. Snijders PJ, van Duin M, Walboomers JM, Steenbergen RD, Risse EK, Helmerhorst TJ, et al. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. Cancer Res 1998; 58:3812-8.
19. Shroyer KR, Thompson LC, Enomoto T, Eskens JL, Shroyer AL, Mcgregor JA. Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix. Am J Clin Pathol 1998; 109:153-62.
20. Zheng PS, Iwasaka T, Yokoyama M, Nakao Y, Pater A, Sugimori H. Telomerase activation in in vitro and in vivo cervical carcinogenesis. Gynecol Oncol 1997; 66:222-6.
21. Pfister H. Relationship of papillomaviruses to anogenital cancer. Obstet Gynecol Clin North Am 1987; 14:349-61.
22. Wilkinson EJ, Smith LJ. Cervical neoplasia. Its association with human papillomavirus infection. J Fla Med Assoc 1993; 80:106-11.
23. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with aging. Nature 1990; 346:866-8.
24. Yashima K, Ashfaq R, Nowak J, Von Gruenigen V, Milchgrub S, Rathi A, et al. Telomerase activity and expression of its RNA component in cervical lesions. Cancer 1998; 82:1319-27.
25. Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996; 2:1033-5.
26. Chen XQ, Bonnefoi H, Pelte MF, Lyautey J, Lederrey C, Movarekhi S, et al. Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 2000; 6:3823-6.
27. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin S, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999; 59:67-70.
28. Albanell J, Lonardo F, Rusch V, Engelhardt M, Langenfeld J, Han W, et al. High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. J Nat Cancer Inst 1997; 89:1609-15.
29. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, et al. Telomerase activity in small cell and non-small cell lung cancers. J Natl Cancer Inst, 1995; 87:895-902.
30. Yashima K, Litzky LA, Kaiser L, Rogers T, Lam S, Wistuba II, et al. Telomerase expression in respiratory epithelium during multistage pathogenesis of lung carcinomas. Cancer Res 1997; 57:2373-7.
31. Arai T, Yasuda Y, Takaya T, Ito Y, Hayakawa K, Toshima S, et al. Application of telomerase activity for screening of primary lung cancer in bronchoalveolar lavage fluid. Oncol Rep 1998; 5:405-8.
32. Xinarianos G, Scott FM, Liloglou T, Prime W, Turnbull L, Walshaw M, et al. Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease. Lung Cancer 2000; 28:37-42.
33. Taga S, Osaki T, Ohgami A, Imoto H, Yasumoto K. Prognostic impact of telomerase activity in non-small cell lung cancers. Ann Surg 1999; 230:715-20.
34. Marchetti A, Bertacca G, Buttitta F, Chella A, Quattrocolo G, Angeletti CA, et al. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer. Clin Cancer Res 1999; 5:2077-81.
35. Xinarianos G, Scott FM, Liloglou T, Prime W, Turnbull L, Walshaw M, et al. Telomerase activity in non-small cell lung carcinomas correlated with smoking status. Int J Oncol 1999; 15:961-5.